CLINICAL_TRIALS trial_result · 2011-06-27

Clinical Trial Update: Safety and Efficacy of Multiple Doses of Canakinumab (ACZ885) in Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 1, Phase 2]

Phase 1/2 clinical trial evaluating safety and efficacy of multiple doses of canakinumab in COPD has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Novartis | Conditions: Chronic Obstructive Pulmonary Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2011-06-27